Question Checklist – Treatment Questions
Being prepared for office visits assists your doctor in determining your medical needs and most appropriate treatment plan; helps you receive timely access to medical care and related services, and created a mutually respectful and supportive relationship. Besides bringing along a companion, one if the best ways to prepare for a visit is prepare a concise list of written questions. Provide a copy for your doctor.
- o What is my diagnosis? And can you please provide me a copy of the pathology report.
- o How widespread is the disease (the stage)?
- o Does the disease require prompt treatment and why?
- o Can the disease be cured?
- o What are the symptoms of the disease, and which indicate a need for treatment?
- o What are my treatment choices?
- o Do you offer radioimmunotherapy as a treatment option?
- o Are new treatments under study? Would a clinical trial be appropriate for me?
- o Which treatment or treatment sequence do you recommend? Why?
NOTE: The rationale for a treatment can be especially important to you when there are
multiple choices and there is no clear best approach. - o What is your level of confidence that the recommended treatment is the best choice?
- o What is the goal of this treatment? (management versus durable remission)
- o What are the chances that the treatment will be successful?
- o Is the collection of stem cells indicated before or after this treatment? When is the best time to consider stem cell harvesting, in general?
- o How long will the treatments last?
- o How long will it take for the treatment to begin working against the disease?
EXAMPLES: Antibiotic therapy for H-pylori can take 12 months or more to show a result
against MALT lymphoma; and Rituxan therapy can take many months before an optimal response is seen. - o How easy is it to administer; will it disrupt my normal life or ability to work?
- o How durable is the response likely to be?
- o What signs will indicate that the therapy is beginning to work or that it is not working?
- o What tests will be used to measure or gauge an early response to treatment?
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
